pubmed-article:16134177 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C1261473 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0076080 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0086960 | lld:lifeskim |
pubmed-article:16134177 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:16134177 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:16134177 | pubmed:dateCreated | 2005-10-10 | lld:pubmed |
pubmed-article:16134177 | pubmed:abstractText | The objective of this study was to evaluate the activity and toxicity of temozolomide given as an extended schedule in patients with advanced sarcoma. | lld:pubmed |
pubmed-article:16134177 | pubmed:language | eng | lld:pubmed |
pubmed-article:16134177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16134177 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16134177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16134177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16134177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16134177 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16134177 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16134177 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:BuesaJose MJM | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:MaurelJoanJ | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:CasadoAntonio... | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:MartinJavierJ | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:Garcia del... | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:BoverIsabelI | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:CruzJosefinaJ | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:Lopez-PousaAn... | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:Martinez-Truf... | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:PovedaAndresA | lld:pubmed |
pubmed-article:16134177 | pubmed:author | pubmed-author:Spanish... | lld:pubmed |
pubmed-article:16134177 | pubmed:copyrightInfo | Copyright 2005 American Cancer Society | lld:pubmed |
pubmed-article:16134177 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16134177 | pubmed:day | 15 | lld:pubmed |
pubmed-article:16134177 | pubmed:volume | 104 | lld:pubmed |
pubmed-article:16134177 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16134177 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16134177 | pubmed:pagination | 1706-12 | lld:pubmed |
pubmed-article:16134177 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:meshHeading | pubmed-meshheading:16134177... | lld:pubmed |
pubmed-article:16134177 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16134177 | pubmed:articleTitle | A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas. | lld:pubmed |
pubmed-article:16134177 | pubmed:affiliation | Department of Medical Oncology, Institut Catala d'Oncologia, Institut d'Investigacio Bellvitge (IDIBELL), Barcelona, Spain. garciadelmuro@iconcologia.net | lld:pubmed |
pubmed-article:16134177 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16134177 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:16134177 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16134177 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16134177 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16134177 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16134177 | lld:pubmed |